The use of graphene-based materials in pharmaceutical nanotechnology has recently received more attention due to their unique chemical structure and physicochemical properties - including an ultra-high surface area, optical, thermal and electrical conductivities, and a good biocompatibility. They can also load large amounts of drug molecules on both sides of the single atom layer sheet. The next generation of cancer nanotheranostics employing graphene-based nanomaterials could address the many challenges associated with traditional chemotherapeutic agents, such as the issues surrounding poor solubility, harmful side effects, non-specific drug distribution, and multi-drug resistance.
&uuid=(email))